Evidence map›Paper›PMID 39598296›Full record

ArticleLife (Basel, Switzerland)2024

The Potential of

Stefan Jelisić, Zoran Stanimirović, Marko Ristanić, Đura Nakarada, Miloš Mojović, Dušan Bošnjaković, Uroš Glavinić

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Metabolic Redox Modulation byMolecules (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stefan JelisićDepartment of Biology, Faculty of Veterinary Medicine, University of Belgrade, Bul. oslobodjenja 18, 11000 Belgrade, Serbia.ORCID 0000-0002-4578-182X
Zoran StanimirovićDepartment of Biology, Faculty of Veterinary Medicine, University of Belgrade, Bul. oslobodjenja 18, 11000 Belgrade, Serbia.ORCID 0000-0003-2657-8591
Marko RistanićDepartment of Biology, Faculty of Veterinary Medicine, University of Belgrade, Bul. oslobodjenja 18, 11000 Belgrade, Serbia.ORCID 0000-0002-6084-7321
Đura NakaradaEPR Laboratory, Faculty of Physical Chemistry, University of Belgrade, Studentski trg 12-16, 11158 Belgrade, Serbia.
Miloš MojovićEPR Laboratory, Faculty of Physical Chemistry, University of Belgrade, Studentski trg 12-16, 11158 Belgrade, Serbia.ORCID 0000-0002-1868-9913
Dušan BošnjakovićDepartment of Physiology and Biochemistry, Faculty of Veterinary Medicine, University of Belgrade, Bul. oslobodjenja 18, 11000 Belgrade, Serbia.ORCID 0000-0003-2711-086X
Uroš GlavinićDepartment of Biology, Faculty of Veterinary Medicine, University of Belgrade, Bul. oslobodjenja 18, 11000 Belgrade, Serbia.ORCID 0000-0003-2143-1611

Funding

Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-65/2024-03/200146Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-66/2024-03/200143Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-66/2024-03/200146Science Fund of the Republic of Serbia No. 5455
6 · The paper itself

Abstract

Global climate change, environmental pollution, and frequent pesticide use severely reduce bee populations, greatly challenging beekeeping. Pesticides such as deltamethrin, a pyrethroid insecticide commonly used to control mosquitoes, can kill individual bees and entire colonies, depending on the exposure. Due to mosquito resistance to pyrethroid insecticides, components that enhance their effect are commonly used. This study explores the potential of

Indexed as

Agaricus bisporusdeltamethrinEPRhoney beesNosema ceranaeoxidative stresspesticides

Identifiers

PMID39598296
PMCPMC11595567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.